![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 10
2018
Rarova, Lucie; Sedlak, David; Oklestkova, Jana; Steigerova, Jana; Liebl, Johanna; Zahler, Stefan; Bartunek, Petr; Kolar, Zdenek; Kohout, Ladislav; Kvasnica, Miroslav und Strnad, Miroslav
(2018):
The novel brassinosteroid analog BR4848 inhibits angiogenesis in human endothelial cells and induces apoptosis in human cancer cells in vitro.
In: Journal of Steroid Biochemistry and Molecular Biology, Bd. 178: S. 263-271
2017
Mandl, Melanie M.; Zhang, Siwei; Ulrich, Melanie; Schmöckel, Elisa; Mayr, Doris; Vollmar, Angelika M. und Liebl, Johanna
(2017):
Inhibition of Cdk5 induces cell death of tumor-initiating cells.
In: British Journal of Cancer, Bd. 116, Nr. 7: S. 912-922
2016
Liebl, Johanna
(2016):
Cyclin dependent kinase 5-a novel target to enhance the antitumor immune response.
In: Translational Cancer Research, Bd. 5:
S587-S589
Unzue, Andrea; Lafleur, Karine; Zhao, Hongtao; Zhou, Ting; Dong, Jing; Kolb, Peter; Liebl, Johanna; Zahler, Stefan; Caflisch, Amedeo und Nevado, Cristina
(2016):
Three stories on Eph kinase inhibitors: From in silico discovery to in vivo validation.
In: European Journal of Medicinal Chemistry, Bd. 112: S. 347-366
Merk, Henriette; Zhang, Siwei; Lehr, Thorsten; Müller, Christoph; Ulrich, Melanie; Bibb, James A.; Adams, Ralf H.; Bracher, Franz; Zahler, Stefan; Vollmar, Angelika M. und Liebl, Johanna
(2016):
Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis.
In: Oncotarget, Bd. 7, Nr. 5: S. 6088-6104
Herzog, Julia; Ehrlich, Sandra M.; Pfitzer, Lisa; Liebl, Johanna; Fröhlich, Thomas; Arnold, Georg J.; Mikulits, Wolfgang; Haider, Christine; Vollmar, Angelika M. und Zahler, Stefan
(2016):
Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1 alpha: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma.
In: Oncotarget, Bd. 7, Nr. 19: S. 27108-27121
2015
Liebl, Johanna; Zhang, Siwei; Moser, Markus; Agalarov, Yan; Demir, Cansaran Saygili; Hager, Bianca; Bibb, James A.; Adams, Ralf H.; Kiefer, Friedemann; Miura, Naoyuki; Petrova, Tatiana V.; Vollmar, Angelika M. und Zahler, Stefan
(2015):
Cdk5 controls lymphatic vessel development and function by phosphorylation of Foxc2.
In: Nature Communications, Bd. 6, 7274
[PDF, 2MB]
2013
Weitensteiner, Sabine B.; Liebl, Johanna; Krystof, Vladimir; Havlíček, Libor; Gucký, Tomáš; Strnad, Miroslav; Fürst, Robert; Vollmar, Angelika M. und Zahler, Stefan
(2013):
Trisubstituted pyrazolopyrimidines as novel angiogenesis inhibitors.
In: PLOS ONE 8(1), e54607 [PDF, 3MB]
In: PLOS ONE 8(1), e54607 [PDF, 3MB]
2012
Regel, Ivonne; Eichenmüller, Melanie; Joppien, Saskia; Liebl, Johanna; Haeberle, Beate; Müller-Höcker, Josef; Vollmar, Angelika M.; Schweinitz, Dietrich von und Kappler, Roland
(2012):
IGFBP3 impedes aggressive growth of pediatric liver cancer and is epigenetically silenced in vascular invasive and metastatic tumors.
In: Molecular Cancer
11:9
[PDF, 4MB]
2011
Reichel, Christoph A.; Uhl, Bernd; Lerchenberger, Max; Puhr-Westerheide, Daniel; Rehberg, Markus; Liebl, Johanna; Khandoga, Andrej; Schmalix, Wolfgang; Zahler, Stefan; Deindl, Elisabeth; Lorenzl, Stefan; Declerck, Paul J.; Kanse, Sandip und Krombach, Fritz
(25. Oktober 2011):
Urokinase-Type Plasminogen Activator Promotes Paracellular Transmigration of Neutrophils Via Mac-1, But Independently of Urokinase-Type Plasminogen Activator Receptor.
In: Circulation, Bd. 124, Nr. 17: S. 1848-1859
[PDF, 4MB]